| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000031984 |
| Receipt No. | R000036382 |
| Official scientific title of the study | Safety and usefulness of preoperative administration of oral nutrient containing arginine, Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA) in patients with colon cancer surgery |
| Date of disclosure of the study information | 2018/03/30 |
| Last modified on | 2018/03/29 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Safety and usefulness of preoperative administration of oral nutrient containing arginine, Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA) in patients with colon cancer surgery | |
| Title of the study (Brief title) | Safety and usefulness of preoperative administration of oral nutrient containing arginine, Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA) in patients with colon cancer surgery | |
| Region |
|
|
| Condition | ||
| Condition | colon cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | It is aimed to evaluate the safety and usefulness of ingesting a nutritient rich in arginine, Eicosapentaenoic acid (EPA), Docosahexaenoic acid (DHA). |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Surgical site infection (SSI) such as wound infection and intraperitoneal abscess. Infectious diseases other than SSI such as respiratory infections and urinary tract infections. Incidence of suture failure. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Subjects take a new Investigational new food "Impact" of 125 ml / 1 pack 4 packs a day from 6 days before the scheduled operation date to 2 days before the scheduled operation date. | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Cases diagnosed as histologically colon cancer. 2. Cases who intestinal resection is scheduled. 3. Cases who can eat by oral ingestion. 4. After receiving sufficient explanation for participation in the research, cases that written consent was obtained. |
|||
| Key exclusion criteria | 1. Cases with intestinal obstruction and high intestinal stenosis. 2. Duplicated cancer cases. 3. Cases with heart dysfunction, liver dysfunction, and kidney dysfunction. 4. Cases who are prescribed prednisolone 6 mg / day cases of steroid. 5. Pregnant women, breast-feeding cases, and cases that may be pregnant. 6. Cases who are observed clear infection foci before registration. 7. Cases after total gastrectomy. 8. Cases with Parkinson's disease; Hoehn and Yahr scale 3 or more. 9. Cases who are prescribed immunosuppressive drugs. 10. Cases with milk allergy and/or soybeans allergy. 11. Case having diabetes with HbA1c 7.0 or higher. 12. Cases considered inappropriate by researchers. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Kazuhiro Sakamoto |
| Organization | Juntendo university |
| Division name | Department of Coloproctological Surgery |
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo |
| TEL | 03-3813-3111 |
| kazusaka@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Toshiaki Hagiwara |
| Organization | Juntendo university |
| Division name | Department of Coloproctological Surgery |
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo |
| TEL | 03-3813-3111 |
| Homepage URL | |
| thagiwa@juntendo.ac.jp | |
| Sponsor | |
| Institute | Juntendo university Department of Coloproctological Surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036382 |